Showing 1061-1070 of 4012 results for "".
The Maternal Brain’s Role in Bone Health: Exploring CCN3’s Potential Power
https://reachmd.com/programs/frontlines-osteoporosis/the-maternal-brains-role-in-bone-health-exploring-cnn3s-potential-power/32343/Based on a recent study’s findings, CCN3 is a hormone released from the maternal brain that triggers skeletal stem cells to form new bone—a discovery that could transform osteoporosis treatment by targeting the condition at its root. Joining Ms. Ashley Baker to explore the key findings and clinicalNurse Practitioners: Founding History and Present Challenges
https://reachmd.com/programs/partners-in-practice/nurse-practitioners-founding-history-and-present-challenges/7062/Nurse Practitioners were first introduced into healthcare systems in 1965 by Loretta C Ford, and since that time the role has expanded to include over 189,000 NP's in practice today. Joining host Mimi Secor to review the first half-century of the Nurse Practitioner profession and its ongoing prioritThe Past and Future of the Nurse Practitioner Profession
https://reachmd.com/programs/partners-in-practice/the-past-and-future-of-the-nurse-practitioner-profession/5548/In 1965, Dr. Loretta Ford, a pediatric nurse at the University of Colorado Medical Center, began to grow concerned about the patients in her community. She saw a need for improved healthcare delivery, especially in the growing number of rural and urban areas where primary pediatric physicians were lA Model to Bring MS Research to Bedside Faster
https://reachmd.com/programs/clinicians-roundtable/a-model-to-bring-ms-research-to-bedside-faster/3601/Speeding up the translation process for MS patients is the mission of Fast Forward, LLC, a venture philanthropy of the National Multiple Sclerosis Society. Our guest today, Dr. Timothy Coetzee executive director of Fast Forward, LLC tells us how they are taking a business venture approach to find cuWhy We'll Never Cure Cancer?
https://reachmd.com/programs/clinicians-roundtable/why-well-never-cure-cancer/2389/What is keeping our society from moving forward in our ability to cure disease? How can what is learned in the lab be brought to the frontlines more quickly and efficiently? How can individual medical institutions work together to make a more profound difference in our healthcare system? Our GuestDietary Guidance in Psoriasis: Evidence-Based Supportive Strategies
https://reachmd.com/programs/frontlines-psoriasis/dietary-guidance-psoriasis-supportive-strategies/39951/Flare patterns, patient concerns, and growing research have brought diet to the forefront of psoriasis care. Tune in as Dr. Peter Lio reviews the strongest evidence behind weight management, gluten sensitivity, and anti-inflammatory nutrition, offering clarity on how diet can support—though not replInnovations in IgAN Care: Addressing Challenges with Therapeutic Advances
https://reachmd.com/programs/clinicians-roundtable/innovations-in-igan-care-addressing-challenges-with-therapeutic-advances/37217/The available treatment options and even the current guidelines for the management of IgA nephropathy (IgAN) come with several limitations. Fortunately, new therapies are on the horizon that can help us address those challenges and slow disease progression in IgAN. Here with Dr. Charles Turck to disThe Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
https://reachmd.com/programs/frontlines-migraine/the-genetics-of-migraine-advancing-diagnosis-and-personalizing-treatment/36156/Decades of research have transformed our understanding of migraine genetics, from rare monogenic types to complex polygenic forms. Mr. Ryan Quigley is joined by Dr. Lyn Griffiths to explore polygenic risk scores, emerging diagnostic tools, and the promise of personalized medicine in migraineSubcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care
https://reachmd.com/programs/project-oncology/subcutaneous-cancer-immunotherapy-at-home-transforming-trials-and-patient-care/35772/As cancer treatment continues to evolve, at-home subcutaneous immunotherapy is at the forefront of decentralized care and research. Here to share his insights on how this delivery model could impact clinical trials and cancer care is Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the UNext Generation Simulators: Where Gaming Meets Clinical Decision-Making
https://reachmd.com/programs/primary-care-today/next-generation-simulators-where-gaming-meets-clinical-decision-making/7417/Case-based simulator software is fast becoming the hottest and most innovative form of medical education in clinical training programs today. Joining Dr. Brian McDonough to update listeners on the origins, rapid evolution, and future horizons of medical simulation is Douglas Seifert, Founder and CEO